Two Colorado studies find resistance mechanisms in ALK+ and ROS1+ cancers


“A University of Colorado Cancer Center study published today in the journal Clinical Cancer Research provides an in-depth look at how these ALK+ and ROS1+ cancers evolve to resist treatment. A second study demonstrates the ability to identify these changes in patient blood samples, perhaps easing the ability to monitor patients for these changes that … Continue reading Two Colorado studies find resistance mechanisms in ALK+ and ROS1+ cancers

Involving ROS1-Positive Cancer Patients in ROS1 Research


Hey ROS1ers: This is an IMPORTANT REQUEST! We all want to find a CURE for our disease, right? To do this, we need to know how many patients are willing and able to participate in ROS1 research. The results will hopefully motivate more patients to join us, generate more interest in collaborative ROS1 research, and … Continue reading Involving ROS1-Positive Cancer Patients in ROS1 Research